These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 21737236)

  • 21. Patient survival, predictive factors and disease course of severe sepsis in Czech intensive care units: A multicentre, retrospective, observational study.
    Uvizl R; Adamus M; Cerny V; Dusek L; Jarkovsky J; Sramek V; Matejovic M; Stourac P; Kula R; Malaska J; Sevcik P
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Jun; 160(2):287-97. PubMed ID: 26526190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of polyclonal immunoglobulins as adjunctive therapy for sepsis or septic shock.
    Kreymann KG; de Heer G; Nierhaus A; Kluge S
    Crit Care Med; 2007 Dec; 35(12):2677-85. PubMed ID: 18074464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluid administration in severe sepsis and septic shock, patterns and outcomes: an analysis of a large national database.
    Marik PE; Linde-Zwirble WT; Bittner EA; Sahatjian J; Hansell D
    Intensive Care Med; 2017 May; 43(5):625-632. PubMed ID: 28130687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of Sepsis Classification and Multidrug-Resistance Status on Outcome Among Patients Treated With Appropriate Therapy.
    Burnham JP; Lane MA; Kollef MH
    Crit Care Med; 2015 Aug; 43(8):1580-6. PubMed ID: 25855900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selenium in Intensive Care (SIC): results of a prospective randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock.
    Angstwurm MW; Engelmann L; Zimmermann T; Lehmann C; Spes CH; Abel P; Strauss R; Meier-Hellmann A; Insel R; Radke J; Schüttler J; Gärtner R
    Crit Care Med; 2007 Jan; 35(1):118-26. PubMed ID: 17095947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improvement in process of care and outcome after a multicenter severe sepsis educational program in Spain.
    Ferrer R; Artigas A; Levy MM; Blanco J; González-Díaz G; Garnacho-Montero J; Ibáñez J; Palencia E; Quintana M; de la Torre-Prados MV;
    JAMA; 2008 May; 299(19):2294-303. PubMed ID: 18492971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of IgM-enriched immunoglobulin preparations in patients with severe sepsis [ISRCTN28863830].
    Tugrul S; Ozcan PE; Akinci O; Seyhun Y; Cagatay A; Cakar N; Esen F
    Crit Care; 2002 Aug; 6(4):357-62. PubMed ID: 12225613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of Serum Phosphate in Mechanically Ventilated Patients With Severe Sepsis and Septic Shock.
    Miller CJ; Doepker BA; Springer AN; Exline MC; Phillips G; Murphy CV
    J Intensive Care Med; 2020 May; 35(5):485-493. PubMed ID: 29519205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of early IgM-enriched immunoglobulin vs polyvalent IgG administration in score-identified postcardiac surgical patients at high risk for sepsis.
    Pilz G; Appel R; Kreuzer E; Werdan K
    Chest; 1997 Feb; 111(2):419-26. PubMed ID: 9041991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N-terminal pro-brain natriuretic peptide and cardiac troponin I for the prognostic utility in elderly patients with severe sepsis or septic shock in intensive care unit: A retrospective study.
    Cheng H; Fan WZ; Wang SC; Liu ZH; Zang HL; Wang LZ; Liu HJ; Shen XH; Liang SQ
    J Crit Care; 2015 Jun; 30(3):654.e9-14. PubMed ID: 25575850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of IgM-enriched immunoglobulin in adult patients with sepsis.
    Kakoullis L; Pantzaris ND; Platanaki C; Lagadinou M; Papachristodoulou E; Velissaris D
    J Crit Care; 2018 Oct; 47():30-35. PubMed ID: 29886064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence of severe sepsis and septic shock in German intensive care units: the prospective, multicentre INSEP study.
    SepNet Critical Care Trials Group
    Intensive Care Med; 2016 Dec; 42(12):1980-1989. PubMed ID: 27686355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Delayed antimicrobial therapy increases mortality and organ dysfunction duration in pediatric sepsis.
    Weiss SL; Fitzgerald JC; Balamuth F; Alpern ER; Lavelle J; Chilutti M; Grundmeier R; Nadkarni VM; Thomas NJ
    Crit Care Med; 2014 Nov; 42(11):2409-17. PubMed ID: 25148597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Impact of Timing of Antibiotics on Outcomes in Severe Sepsis and Septic Shock: A Systematic Review and Meta-Analysis.
    Sterling SA; Miller WR; Pryor J; Puskarich MA; Jones AE
    Crit Care Med; 2015 Sep; 43(9):1907-15. PubMed ID: 26121073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of propionic acid at diagnosis predicts mortality in patients with septic shock.
    Weng J; Wu H; Xu Z; Xi H; Chen C; Chen D; Gong Y; Hua Y; Wang Z
    J Crit Care; 2018 Feb; 43():95-101. PubMed ID: 28863283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early therapy with IgM-enriched polyclonal immunoglobulin in patients with septic shock.
    Cavazzuti I; Serafini G; Busani S; Rinaldi L; Biagioni E; Buoncristiano M; Girardis M
    Intensive Care Med; 2014 Dec; 40(12):1888-96. PubMed ID: 25217146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of appropriate antimicrobial therapy for patients with severe sepsis and septic shock--a quality improvement study.
    Yokota PK; Marra AR; Martino MD; Victor ES; Durão MS; Edmond MB; dos Santos OF
    PLoS One; 2014; 9(11):e104475. PubMed ID: 25375775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The DISPARITY-II study: delays to antibiotic administration in women with severe sepsis or septic shock.
    Madsen TE; Napoli AM
    Acad Emerg Med; 2014 Dec; 21(12):1499-502. PubMed ID: 25424151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. sTREM-1 predicts intensive care unit and 28-day mortality in cancer patients with severe sepsis and septic shock.
    Ravetti CG; Moura AD; Vieira ÉL; Pedroso ÊR; Teixeira AL
    J Crit Care; 2015 Apr; 30(2):440.e7-13. PubMed ID: 25541104
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of low-dose acetylsalicylic acid and atherosclerotic vascular diseases on the outcome in patients with severe sepsis or septic shock.
    Otto GP; Sossdorf M; Boettel J; Kabisch B; Breuel H; Winning J; Lösche W
    Platelets; 2013; 24(6):480-5. PubMed ID: 22994591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.